BioSpace News Archive

Pharm Country

Q BioMed Prices $5.5M Public Offering

Q Biomed is pleased to announce pricing of a public offering of an aggregate of 1,711,875 shares of common stock of the Company.

January 30, 2018
·
5 min read
Business

Optibrium Expands U.S. and U.K. Operations

Optibrium today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge Innovation Park, Cambridge, UK.

January 30, 2018
·
2 min read
Business

FDA, USDA Announce Formal Agreement to Bolster Coordination and Collaboration

The formal agreement outlines efforts to increase interagency collaboration, efficiency and effectiveness on produce safety and biotechnology activities, while providing clarity to manufacturers.

January 30, 2018
·
5 min read
Planmeca Emerald Intraoral Scanner Now Accepted by the WIN System

WIN lingual braces work in the same way as conventional fixed braces, with full control and movement of the teeth, but they are invisible from the outside.

January 30, 2018
·
2 min read
Business

Agilent Partners with Science Exchange

The partnership will promote access to Agilent-enabled services to the research community worldwide.

January 30, 2018
·
3 min read
Policy

EMA Grants Rexgenero’s Lead Product REX-001 Advanced Therapy Medicinal Product Certificate for Manufacturing Quality and Non-Clinical Data

The EMA certification paves the way for the MAA of its lead product REX-001, a novel cell therapy currently in a Phase III programme for the treatment of CLI.

January 30, 2018
·
1 min read
Genetown

PCI Synthesis Submits Patent for Synthesizing Azelaic Acid

Azelaic Acid is used for producing industrial products including polyesters, plasticizers and lubricants and is a component in skin-care products.

January 30, 2018
·
1 min read
Business

INSYS Therapeutics Adds Two New Executives to Senior Management Team

The company added two new execs to its management team.

January 30, 2018
·
2 min read
Business

Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results

The Company reported fourth quarter net sales of $2.074 billion.

January 30, 2018
·
68 min read
Business

DNA Script and Dynamic Combinatorial Chemistry Enter Exclusive Partnership to Enable Enzymatically Synthesized DNA

DNA Script and Dynamic Combinatorial Chemistry (DCC) announced today an exclusive licensing agreement that will expand the use by DNA Script of a novel DNA building block, commercialized by DCC, to synthesize high purity synthetic DNA and other nucleic acids.

January 30, 2018
·
4 min read